Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NeuroTherm moves into vertebroplasty by purchasing ArthroCare product lines

This article was originally published in Clinica

Executive Summary

Chronic pain treatment firm NeuroTherm is expanding into the spinal surgery market by acquiring two product lines from minimally-invasive surgery specialist ArthroCare. The first, Parallax, is used during vertebroplasty, a procedure where bone cement is injected into the vertebra to relieve the pain of spinal fractures. ArthroCare acquired the product with its $28m purchase of spinal company Parallax in 2004 (www.clinica.co.uk, 31 October 2003). The second product, Contour, is designed for cavity creation, a step in the vertebroplasty process.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT097556

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel